Nafcillin Inj Rx
Generic Name and Formulations:
Nafcillin sodium 1g/vial, 2g/vial, 10g/vial; pwd for deep IM inj after reconstitution, IV inj or IV drip after reconstitution and dilution.
Various generic manufacturers
Indications for Nafcillin Inj:
Susceptible infections due to penicillinase-producing staphylococci.
Give by deep IM gluteal inj, or IV inj over 5–10 mins, or short-term IV drip for 24–48 hours. IM: 500mg every 4–6 hours. IV: 500mg every 4 hours. Severe infections: 1g IM or IV every 4 hours; treat for at least 14 days, then continue for at least 48 hours after becoming afebrile, asymptomatic, or (–) cultures. Endocarditis or osteomyelitis: may need longer therapy; see literature. Switch to oral therapy as soon as clinically indicated.
Give by deep IM gluteal inj only. Neonates: 10mg/kg twice daily. Infants and children <40kg: 25mg/kg twice daily.
Cephalosporin or other allergy: not recommended. Asthma. Renal impairment: consider dose reduction. Do CBCs, BUN, urinalysis, creatinine levels prior to and weekly during therapy. Monitor renal, hepatic and hematopoietic function in prolonged use. Elderly (esp. IV route). Newborns (monitor). Pregnancy (Cat.B). Nursing mothers.
May be antagonized by tetracycline; avoid. Potentiated by probenecid.
Inj site reactions, rash, serum sickness, GI upset, anaphylaxis, neuropathy, nephropathy, blood dyscrasias.
Formerly known under the brand names Nallpen, Unipen.
Renal and Urology News Articles
- CROWNWeb Reporting Gets Up to Speed With Implementation of Dashboard
- Prostate Cancer Gene Testing Guidelines Issued
- Radical Nephrectomy Linked With Worse Kidney Function, Survival
- Acute Kidney Injury Increases Risk for Hypoglycemia in Diabetes Pts
- USPSTF Questions Nontraditional CVD Risk Factors for Assessment
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)